Get Q3 2025 IRADIMED (IRMD) earnings insights: record revenue, new MRI IV pump launch, raised full-year guidance, and 2026 growth outlook.

Treating patients at home with IV antibiotics, rather than in a clinical setting, could halve costs to the NHS and relieve ...

Treating patients at home with IV antibiotics, rather than in a clinical setting, could halve costs to the NHS and relieve pressure on hospital beds - according to a University of East Anglia study.

Treating patients with IV antibiotics at home, rather than in a clinical setting, could ease pressure on hospital beds, research suggests.

Identifying and managing operational 'suffering' points is crucial for efficiency and minimising downtime in mining ...

Medical spas bill intravenous fluid drips as a way to enhance health. Detractors say the industry is unregulated and that ...

After Hurricane Helene knocked out a North Carolina plant that supplies much of the IV fluid hospitals depend upon, MUSC ...

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 third quarter financial results before the market opens on Monday, November 3, 2025. Iradimed management will ...

Artificial Intelligence is becoming increasingly more common in nearly every aspect of life, including our healthcare. So how ...

For patients like Pham, Vantive’s home dialysis technologies represent more than medical equipment — they’re a pathway to a ...